Natus Medical Inc. (BABY)

32.50
0.70 2.10
NASDAQ : Health Technology
Prev Close 33.20
Day Low/High 32.45 / 33.40
52 Wk Low/High 28.00 / 43.60
Avg Volume 235.20K
Exchange NASDAQ
Shares Outstanding 34.07M
Market Cap 1.13B
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week of BABY July 2018 Options Trading

First Week of BABY July 2018 Options Trading

Investors in Natus Medical Inc. saw new options become available this week, for the July 2018 expiration.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALOT, BOOM, BWA, DAR, EHTH, ESRT, ETR, FNGN, FOE, FPO, FSS, GGG, KKR, KRA, MSCC, TOT, TZOO, WMAR Downgrades: BABY, CREG, DEPO, ETH, EXPE, GNRC, SPOK, TDC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

DEADLINE ALERT: Brower Piven Reminds Investors Of The March 31, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess Of $100,000 From Investment In Natus Medical Incorporated To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...

BABY SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Natus Medical Incorporated And A Lead Plaintiff Deadline Of March 31, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Natus Medical Incorporated (NASDAQ: BABY)...

TheStreet Quant Rating: C- (Hold)